Acanthamoeba induces cell-cycle arrest in host cells by Sissons, J. et al.
Journal of Medical Microbiology (2004), 53, 711–717 DOI 10.1099/jmm.0.45604-0




Received 20 January 2004
Accepted 15 March 2004
Acanthamoeba induces cell-cycle arrest in host cells
James Sissons,1 Selwa Alsam,1 Samantha Jayasekera,1 Kwang Sik Kim,2
Monique Stins2 and Naveed Ahmed Khan1
1School of Biological and Chemical Sciences, Birkbeck College, University of London, London WC1E
7HX, UK
2Pediatric Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD, USA
Acanthamoeba can cause fatal granulomatous amoebic encephalitis (GAE) and eye keratitis.
However, the pathogenesis and pathophysiology of these emerging diseases remain unclear. In this
study, the effects of Acanthamoeba on the host cell cycle using human brain microvascular
endothelial cells (HBMEC) and human corneal epithelial cells (HCEC) were determined. Two
isolates of Acanthamoeba belonging to the T1 genotype (GAE isolate) and T4 genotype (keratitis
isolate) were used, which showed severe cytotoxicity on HBMEC and HCEC, respectively. No
tissue specificity was observed in their ability to exhibit binding to the host cells. To determine the
effects of Acanthamoeba on the host cell cycle, a cell-cycle-specific gene array was used. This
screened for 96 genes specific for host cell-cycle regulation. It was observed that Acanthamoeba
inhibited expression of genes encoding cyclins F andG1 and cyclin-dependent kinase 6, which are
proteins important for cell-cycle progression. Moreover, upregulation was observed of the
expression of genes such as GADD45A and p130 Rb, associated with cell-cycle arrest, indicating
cell-cycle inhibition. Next, the effect of Acanthamoeba on retinoblastoma protein (pRb)
phosphorylation was determined. pRb is a potent inhibitor of G1-to-S cell-cycle progression;
however, its function is inhibited upon phosphorylation, allowing progression into S phase.Western
blotting revealed that Acanthamoeba abolished pRb phosphorylation leading to cell-cycle arrest at
the G1-to-S transition. Taken together, these studies demonstrated for the first time that
Acanthamoeba inhibits the host cell cycle at the transcriptional level, as well as by modulating pRb
phosphorylation using host cell-signalling mechanisms. A complete understanding of
Acanthamoeba–host cell interactions may help in developing novel strategies to treat
Acanthamoeba infections.
INTRODUCTION
Acanthamoeba are the causative agents of life-threatening
granulomatous amoebic encephalitis (GAE) in immuno-
compromised patients (Jones et al., 1975; Martinez, 1987; Di
Gregorio et al., 1992; Friedland et al., 1992; Gonzalez et al.,
1986;Gordon et al., 1992) and a common amoebic keratitis, a
sight-threatening disease of the eye, which is mostly asso-
ciated with contact-lens use (Chynn et al., 1995; Moore &
McCulley, 1989; Wright et al., 1985; Mathers et al., 1996;
Niederkorn et al., 1999; Marciano-Cabral & Cabral, 2003;
Khan, 2003). In addition, Acanthamoeba have been asso-
ciated with cutaneous lesions and sinusitis in immunocom-
promised patients (reviewed by Marciano-Cabral & Cabral,
2003). Over the past few decades, Acanthamoeba infections
have remained significant and are on the rise. This is due to
increasing populations of contact-lens wearers and immu-
nocompromised patients, as well as improved awareness and
detection of these emerging diseases. However, the precise
mechanisms associated with the pathogenesis and patho-
physiology of Acanthamoeba infection remain unclear. The
clinical outcome of Acanthamoeba infection is dependent on
the virulence of the parasites, the hosts and environmental
factors (Khan, 2003). Given their complexity, it is not
surprising that Acanthamoeba interactions with host cells
result in the stimulation of diverse signalling pathways,
which ultimately results in the well-documented Acantha-
moeba-produced host cell cytotoxicity (Khan, 2003; Cao
et al., 1998; Leher et al., 1998; De Jonckheere, 1983). Other
studies have shown that Acanthamoeba produces apoptosis
in murine neuroblastoma cells (Alizadeh et al., 1994).
Apoptosis, or programmed cell death, is known to be
dependent on host cell signalling. Overall, these studies
suggested that interactions of Acanthamoeba with host cells
stimulated specific host cell signalling pathways, resulting in
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host cell death. We hypothesized that Acanthamoeba could
influence the proliferation of host cells, as well as inducing
host cell apoptosis. In this study, we determined the effects of
Acanthamoeba on the host cell cycle. Using cell-cycle-specific
gene array analyses, we determined that Acanthamoeba
inhibited DNA synthesis, inducing host cell-cycle arrest,
one of the earliest events in Acanthamoeba-produced host
cell apoptosis/cytotoxicity. These data were further con-
firmed at the protein level by studying the phosphorylation of
the retinoblastoma protein (pRb), a master regulator of the
cell cycle. Hyperphosphorylation of pRb is crucial for cell-
cycle progression from G1 to S phase. We showed that
Acanthamoeba induced pRb dephosphorylation in host cells
resulting in G1-to-S phase checkpoint arrest. This is the first
report to show that Acanthamoeba induces host cell-cycle
arrest.
METHODS
All chemicals were purchased from Sigma, unless otherwise stated.
Acanthamoeba cultures. Two pathogenic Acanthamoeba isolates
were used in this study. The first, belonging to the T1 genotype, was
isolated from a GAE case (ATCC 50494) and the second, belonging to
the T4 genotype, was isolated from a keratitis case (ATCC 50492).
Parasites were routinely grown in PYGmedium [0.75% (w/v) proteose
peptone, 0.75% (w/v) yeast extract and 1.5% (w/v) glucose] at 30 8C in
tissue culture flasks and the medium was refreshed 17–20 h prior to
experiments, as described previously (Khan et al., 2000). This resulted in
.99% of Acanthamoeba in trophozoite forms.
Human brain microvascular endothelial cells (HBMEC). Primary
BMEC from a human origin were isolated and cultured as described
previously (Alsam et al., 2003). Briefly, HBMEC were purified by
fluorescence-activated cell sorting and their purity was tested using
endothelial markers such as expression of F-VIII, carbonic anhydrase IV
and uptake of acetylated low-density lipoprotein, resulting in .99%
pure cultures. HBMECwere routinely grown on rat tail collagen-coated
dishes in RPMI 1640 containing 10% heat-inactivated fetal bovine
serum, 10% Nu-Serum, 2 mM glutamine, 1 mM pyruvate, 100 U
penicillin ml1, 100 g streptomycin ml1, non-essential amino acids
and vitamins (Alsam et al., 2003).
Human corneal epithelial cells (HCEC). Immortalized HCEC were
routinely cultured as described previously (Araki-Sasaki et al., 2000).
Briefly, HCEC were grown in RPMI 1640 containing 10% fetal calf
serum and 2 mM glutamine. Under these conditions, HCEC exhibited
corneal epithelial cell-specific properties, as described previously
(Araki-Sasaki et al., 2000). For adhesion and cytotoxicity assays, both
HBMEC andHCECwere grown in 24-well plates by incubating 106 cells
per well. For gene array and Western blotting assays, HBMEC and
HCECwere grown in 60 mmdishes at a density of 33 106 cells per well.
Cytotoxicity assay. To determine the pathogenic potential of each
isolate used in this study, cytotoxicity assays were performed as
described previously (Khan, 2001). Briefly, both HBMEC and HCEC
were grown to confluence in 24-well plates. Acanthamoeba isolates
(5 3 105 amoebae per well) were incubated with cell monolayers in
serum-free media (RPMI 1640 containing 2 mM glutamine, 1 mM
pyruvate and non-essential amino acids) at 37 8C in a 5% CO2
incubator for up to 24 h. At the end of this incubation period,
supernatants were collected and cytotoxicity was determined by meas-
uring lactate dehydrogenase (LDH) release (Cytotoxicity Detection kit;
Roche Applied Science). Briefly, conditioned media of co-cultures of
Acanthamoeba and host cells were collected and the cytotoxicity (%
LDH) was detected as follows: % cytotoxicity ¼ (sample valuecontrol
value)/(total LDH releasecontrol value) 3 100. Control values were
obtained from host cells incubated in RPMI 1640 alone. Total LDH
release was determined fromhost cells treatedwith 1%TritonX-100 for
30 min at 37 8C.
Adhesion assays. For adhesion assays, Acanthamoeba were metabo-
lically labelled by culturing 5 3 106 amoebae ml1 in PYG medium
containing 100 Ci [35S]methionine (Pharmacia Biotech) at 30 8C for
18 h as described previously (Alsam et al., 2003). Radiolabelled amoebae
(.95% trophozoites) were collected by centrifugation at 750 g for
10 min and resuspended in 20 ml PBS containing 0.1 mM CaCl2 (PBS-
Ca). This process was repeated three times to remove unincorporated
[35S]methionine. Finally, amoebae (2 3 105 amoebae per well) in
suspension in 200 l RPMI 1640 were incubated with HBMEC and
HCEC grown in 24-well plates for 1 h at room temperature. Unbound
amoebae were removed gently by three washes using PBS-Ca before the
addition of 0.4 ml 2% SDS in PBS-Ca to solubilize the host cells and
bound amoebae. The specific radioactivity was counted using a
scintillation counter.
To test the effect of saccharides, amoebae (2 3 105) were incubatedwith
various saccharides [Æ-D-mannopyranoside (Æ-mannose), xylose,
Æ-fucose and -galactose, all at a final concentration of 100 mM] in
100 l RPMI 1640 for 30 min prior to the adhesion assay. For controls,
amoebae were incubated with BSA.
Cell-cycle-specific gene array. To determine whether Acanthamoeba
altered cell-cycle-related gene expression, a cell-cycle-specific gene array
was employed (Superarray) according to the manufacturer’s instruc-
tions. Briefly, both HBMEC and HCEC were grown to 95% confluence
in 60 mm plates and incubated with Acanthamoeba trophozoites
(5 3 106 per plate). The GAE isolate was incubated with HBMEC,
while the keratitis isolate was incubated with HCEC. Plates were
incubated at 37 8C in 5% CO2 for 30 min. For controls, HBMEC and
HCEC were incubated alone under similar conditions. Following this
incubation, cells were washed three times with PBS-Ca and RNA was
isolated using an RNAqueous kit (Ambion) according to the manufac-
turer’s instructions. RNA purity and quantity was determined by
measuring absorbance at 260 and 280 nm using a spectrophotometer
and confirmed by RNA agarose gel analysis (Khan et al., 2003).
For array analyses, 5 gRNAwas converted to cDNAusing a primermix
(Superarray) specific for 96 cell-cycle-specific genes (the list of genes
tested in this study is available at http://www.superarray.com/gene_
array_table/xpd_HS-001_table.pdf). Reactions were carried out using
the Moloney murine leukaemia virus reverse transcriptase and biotin–
16-dUTP (Promega) to produce a biotinylated cDNA probe. cDNA
probes from infected and uninfected cells were hybridized with separate
membranes overnight at 60 8C. Themembranes were washed twice with
5 ml wash buffer A (2 3 SSC, 1% SDS) at 60 8C for 5 min and twice
withwash buffer B (0.1 3 SSC, 0.5%SDS) at 60 8C for 5 min, according
to themanufacturer’s instructions. The cDNA probe was detected using
1 ml CDP-Star detection solution (Superarray). Images generated by
scanning were analysed using SCANALYSE software (available at http://
rana.Stanford.edu/software) to determine the approximate fold change
for each spot on the array following normalization of control genes on
the two arrays (GEArray Analyser; Superarray). Levels of gene expres-
sion of more than 2-fold and , 0.3-fold were considered to be
significantly up- or downregulated, respectively, according to the
manufacturer’s instructions.
Western blotting.Western blotting was performed to determine pRb
phosphorylation as described previously (Khan et al., 2002). Briefly,
HBMEC andHCECwere grown asmonolayers in 60 mmdishes and the
cells were incubated with Acanthamoeba (approx. 5 3 106) for various
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intervals of time. Unbound amoebae were removed by several washes
and cells were lysed with RIPA lysis buffer (50 mM Tris/HCl, pH 7.4,
0.1% SDS, 0.5% sodiumdeoxycholate, 10mMsodiumpyrophosphate,
25mM -glycerophosphate, 150mMNaCl, 2mMEDTA, 2mMEGTA,
1% Triton X-100, 1 mM Na3VO4, 50 mM NaF, 1 mM PMSF, 1 g
aprotonin ml1, 1 g leupeptin ml1 and 1 g pepstatin ml1). For
immunoprecipitation, equal amounts of cell lysates (0.5–1 mg) were
incubated with antibodies against phospho-Rb including the phospho-
pRb Ser780, Ser795 and Ser807/811 residues (Cell Signalling Technol-
ogy) overnight at 4 8C. Following this, 50 l Protein A–agarose beads
(Qiagen) was added for 1 h to collect the antigen–antibody complex.
Antigen–antibody complexes were washed three times and analysed by
7.5% SDS-PAGE. Proteins were transferred onto a nitrocellulose
membrane. Membranes were blocked in 4% blocking solution (Bio-
Rad) in PBS-Ca and immunoblotted using a primary mAb against total
pRb (Cell Signalling Technology) overnight at 4 8Cwith gentle shaking.
Next day, membranes were washed and subsequently incubated
(60 min, 22 8C) with horseradish peroxidase-linked secondary anti-
body. In the controls, half of the cell lysates were immunoprecipitated
and immunoblotted using anti-pRb antibody. A single band of anti-
body-bound pRbwas visualized using an enhanced chemiluminescence
kit (Amersham Biosciences).
RESULTS AND DISCUSSION
Acanthamoeba isolates belonging to genotypes T1
and T4 do not exhibit tissue specificity in host cell
binding
Two clinical isolates of Acanthamoeba belonging to the T1
genotype (GAE isolate) and T4 genotype (Keratitis isolate)
were used and their binding determined using HBMEC and
HCEC. We observed that both isolates exhibited more than
78% binding to both HCEC and HBMEC. Furthermore,
binding was significantly inhibited in the presence of
exogenous Æ-mannose (P , 0.01), indicating the role of
mannose-binding protein (MBP). It was interesting to note
that.75% of the binding of the keratitis isolate was blocked
using Æ-mannose, irrespective of the cell type. Æ-Mannose
inhibited approximately 50% of the binding of the GAE
isolate to both HCEC and HBMEC cell types, suggesting the
role of other determinants in binding of the GAE isolate to
host cells (Fig. 1).
Acanthamoeba isolates belonging to genotypes T1
and T4 exhibit severe host cell cytotoxicity
The pathogenic potential of the keratitis (T4) and GAE (T1)
isolates was determined using HBMEC and HCEC. The T4
isolate produced 74  3.5 and 80  4.2% cytotoxicity in
HBMEC and HCEC, respectively. Similarly, the T1 isolate
produced 80  2.6 and 77  5.6% cytotoxicity in HBMEC
and HCEC, respectively. Overall, these results indicated that
both isolates are potential pathogens and exhibit severe
cytotoxicity, irrespective of the cell type.
Gene array analyses demonstrate inhibition of the
cell cycle
To determine the effects of Acanthamoeba on the cell cycle of
HBMEC and HCEC, a cell-cycle-specific gene array was
employed to screen for 96 genes important in cell-cycle
regulation. We observed that Acanthamoeba induced signifi-
cant changes in the expression of 18 genes encoding proteins
that regulate cell-cycle progression in HBMEC (Table 1).
These included genes such as cyclins D2, D3, F, G1, CDK6
and p130RB2, which encode proteins important for G1-to-S
progression in the cell cycle (Gillett &Barnes, 1998; Pietenpol
& Stewart, 2002; Poggioli et al., 2002). Moreover, significant
upregulation of the expression of genes such as GADD45 and
CDC6 was observed. GADD45 is known to inhibit cyclin-
dependent kinase-1 (CDK1) by physically dissociating the
CDK1–cyclin B complex, eliminating CDK1 activity and
resulting in G2-to-M checkpoint arrest (Zhan et al., 1999).
Overall, our data showed that Acanthamoeba induced
alterations in the expression of genes encoding proteins
required for cell-cycle progression. Similar results were
obtained with Acanthamoeba interactions with HCEC (data
not shown).
Acanthamoeba inhibits pRb phosphorylation,
inducing cell-cycle arrest at the G1-to-S checkpoint
To determine the significance of our findings at the protein
level, we studied the effect of Acanthamoeba on the host cell
pRb, a master regulator of the cell cycle (Harbour & Dean,
2000;Dyson, 1998; Stevaux&Dyson, 2002). pRb controls the
G1-to-S transition of the cell cycle by directly associatingwith
the transactivation domain of E2F and blocking the ability of
E2F to activate transcription of genes (G1 arrest), which is
required for G1-to-S phase progression. However, upon
stimulation with growth signals, pRb becomes phosphory-
lated and dissociates from the E2F transcription factors,


















Fig. 1. Acanthamoeba isolates belonging to genotypes T1 (GAE
isolate) and T4 (keratitis isolate) exhibit similar binding to HBMEC
(open bars) and HCEC (filled bars). Acanthamoeba GAE and keratitis
isolates were radiolabelled with [35S]methionine and added to mono-
layers of HCEC and HBMEC (5 3 105 amoebae per well) in the
presence or absence of 100 mM Æ-D-mannopyranoside (man).
Cultures were incubated at room temperature for 1 h as described
in Methods. The specific radioactivity of bound amoebae was
determined using a scintillation counter. Results indicate means of
three separate experiments performed in triplicate. T1 and T4 isolates
exhibited similar binding to HCEC and HBMEC, which was inhibited
significantly in the presence of exogenous Æ-mannose. Æ-Mannose
inhibited .75 % of the binding of the keratitis isolate to both HCEC
and HBMEC compared with 50 % inhibition of binding of the GAE
isolate.
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determine the effects of Acanthamoeba on pRb phosphoryla-
tion, HBMEC and HCEC were incubated with Acanthamoe-
ba followed by immunoprecipitation and Western blotting
using anti-phospho-pRb and anti-pRb antibodies, respec-
tively. We observed that HBMEC and HCEC exhibited pRb
dephosphorylation in response to Acanthamoeba (Fig. 2).
This pRb dephosphorylation was observed in a time-depen-
dent manner, indicating the role of host cell signalling. It was
interesting to note that HCEC showed a similar pattern, but
over a longer time period (Fig. 2b), and that this delayed
response was observedwith both T1 and T4 isolates (data not
shown). Overall, our data showed that Acanthamoeba–host
cell interaction abolishes pRb phosphorylation, resulting in
cell-cycle arrest.
Several lines of evidence suggest that Acanthamoeba pro-
duces severe host cell cytotoxicity (Cao et al., 1998; De
Jonckheere, 1983; Khan, 2001; Leher et al., 1998), which
correlates with clinical findings of painful, blinding keratitis
and a fatal encephalitis (GAE). However, the underlying
mechanisms leading to the pathological features associated
with Acanthamoeba infection remain unclear. In this study,
we demonstrated that Acanthamoeba induces host cell-cycle
arrest, a primary step in the pathogenesis of Acanthamoeba-
mediated host cell cytotoxicity.
As indicated above, Acanthamoeba are known to produce
two recognized diseases, GAE and keratitis. For biological
relevance, we used a GAE isolate of Acanthamoeba belonging
to the T1 genotype and studied its effect on HBMEC.
Similarly, a keratitis isolate belonging to the T4 genotype
was used for HCEC. We did not observe tissue specificity
with Acanthamoeba binding to the host cells. This could be
due the fact that the Acanthamoeba isolates tested in this
study are capable of producing both diseases and/or that
initial binding of Acanthamoeba to host cells requires merely
the presence ofmannose residues on the host cells. In support
of the second hypothesis, previous reports have shown that
Acanthamoeba exhibit binding to various cell types including
rabbit corneal epithelial cells (Morton et al., 1991; Yang et al.,
1997), pig corneal epithelium (van Klink et al., 1992),
Chinese hamster corneal epithelium (van Klink et al.,
1993), human corneal fibroblasts (Badenoch et al., 1995)
and rat microglial cells (Shin et al., 2001), as well as to tissue




CCND2 (cyclin D2) Required for G1-to-S transition
CCND3 (cyclin D3) Required for G1-to-S transition
RBL2 (p130RB2) G1-to-S checkpoint arrest
SKP1A Cell-cycle inhibition
CUL5 Induces apoptosis, cell-cycle arrest, tumour suppressor, cell-cycle regulation
S phase
CDC6 Negative regulation of DNA replication, negative regulation of cell proliferation, interferes with
progression through G2
MCM7 (CDC47) DNA replication
DNA damage checkpoint
GADD45A Induces G2 arrest
NBS1 Required for homologous recombination repair, telomere length regulation and maintenance of chromatin
structure
RAD17 DNA damage-induced cell-cycle arrest in G2 phase
RAD50 DNA double-strand break repair, cell-cycle checkpoint activation, telomere maintenance and meiotic
recombination




CDK6 (cyclin-dependent kinase 6) Important for G1-to-S transition by phosphorylation of pRb
CUL4A G1-to-S transition of mitotic cell cycle, induction of apoptosis, cell-cycle arrest
S phase
CCNG1 (cyclin G1) Controls p53–Mdm2 network
G2 phase
CCNF (cyclin F) Cell-cycle regulation (mitosis)
M phase
CDC27 Cell proliferation
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culture plates coated with mannose–BSA (Yang et al., 1997),
and binding is mediated by MBP. Consistent with these
findings, we observed that the initial binding of Acantha-
moeba to both cell typeswasmediated byMBP.Moreover, we
have recently shown that Acanthamoeba isolates exhibiting
higher levels of MBP expression showed increased cytotoxi-
city to host cells (Alsam et al., 2003), indicating thatMBP is a
potential marker for the differentiation of pathogenic
Acanthamoeba. As indicated above,Acanthamoeba-mediated
host cell cytotoxicity did not exhibit tissue specificity. This
may be due to the longer incubations (24 h) required for
cytotoxicity assays. Further assays of cell death that require
shorter incubationsmay help to determinewhetherAcantha-
moeba-mediated host cell death is genotype dependent or
requires tissue specificity. Overall, these data suggest that the
initial binding of pathogenic Acanthamoeba is mediated by
MBP, but isolates expressing MBP undoubtedly possess
other virulence factors that determine their ability to
produce GAE, keratitis or both. Further studies are in
progress to address these issues.
We next determined the effects of Acanthamoeba on the host
cell cycle, both at the transcriptional and the protein level. A
cell-cycle-specific gene arraywas employed. It was interesting
to note that we observed a greater than 2.5-fold increase in
GADD45 gene expression. GADD45 protein is known to
inhibit CDK1 by physically dissociating the CDK1–cyclin B
complex, eliminating CDK1 activity and resulting in G2-to-
M checkpoint arrest (Zhan et al., 1999). In the normal cell
cycle, CDK1 is phosphorylated when bound to cyclin B,
which subsequently leads to phosphorylation of structural
proteins in the nucleus including nucleolin, nuclear lamins
and vimentins, leading to the initiation of mitosis and
cellular division. However, our data suggested that Acantha-
moeba induced increased levels of GADD45 gene expression,
resulting in CDK1 inhibition leading to G2-to-M phase
checkpoint arrest. Another interesting finding was the
significantly increased level of RBL2 (p130RB2) gene expres-
sion. RBL2 is a member of the pRb family, which are critical
regulators of G1-to-S phase transition in the cell cycle.
Members of the pRb family include pRb, p130 and p107,
which associate with E2F transcriptions factors, regulators of
the cell cycle (Harbour&Dean, 2000;Dyson, 1998; Stevaux&
Dyson, 2002). So far, six E2F proteins have been identified,
divided into three categories. E2F1–E2F3 bind exclusively to
pRb and are known to be transcriptional activators required
to induce S-phase entry. E2F4 binds with high affinity to
p107 and p130, and E2F5 associates with p130. E2F6 does not
bind to any pRb family proteins but associates with Poly-
comb proteins. However, E2F4–E2F6 are known to act as
transcriptional repressors. Moreover, p130–E2F complexes
are found in quiescent or differentiated cells, while p107–
E2F complexes are found in S-phase cells. Our data demon-
strated that Acanthamoeba induces increased levels of p130
gene expression, clearly indicating that host cells undergo
G1-to-S phase checkpoint arrest in response to Acanthamoe-
ba. It was interesting to note that we did not observe any
changes in the levels of pRb gene expression. This was an
interesting finding, as it is well documented that the role of
pRb is crucial in cell-cycle regulation. One possible explana-
tion for our findings is that structural modifications of pRb
occurred, rather than changes in the amounts of pRb in the
cells. Indeed, pRb binds directly to the transactivation
domain of E2F and blocks the ability of E2F to activate
transcription of genes (G1 arrest), which is required for
G1-to-S phase progression. However, upon stimulation to
enter S phase, pRb becomes phosphorylated by CDKs at
Ser249/252, Thr373, Ser780, Ser795 and Ser807/811 residues.
This leads to pRb dissociation from the E2F transcription
factors, allowing E2F to relocate to the nucleus and act as a
transcriptional activator. To determine pRbmodifications at
the protein level, we used three antibodies generated against
phospho-pRb Ser780, Ser795 and Ser807/811, and a control
antibody generated against total pRb. We observed that
Acanthamoeba induced pRb dephosphorylation in host cells,
a marker of G1-to-S phase checkpoint arrest. Although we
observed pRb dephosphorylation in both HBMEC and
HCEC, HCEC required longer incubations with Acantha-
moeba to exhibit similar effects. This delayed response was
observed with both the T1 and T4 isolates. This could be due
to the cells being of different origins (corneal epithelial cells
versus brain microvascular endothelial cells) and/or the fact
that HCEC are immortalized cells while HBMEC are primary
in nature. Further studies are in progress to address these
Phospho-pRB IP  α-phospho-pRB
WB  α-pRB
Total pRB
Control 0·5 1 2 3 4 (h)







HCEC  amoeba (T1 isolate)




Fig. 2. (a) Genotype T1 Acanthamoeba isolate induces pRB depho-
sphorylation in HBMEC. HBMEC were grown in 60 mm dishes and
incubated with the T1 isolate (approx. 2 3 106 amoebae) as de-
scribed in Methods. Proteins were immunoprecipitated (IP) with anti-
phospho-pRb antibodies (Æ-phospho-pRb) and Western blotted (WB)
with anti-Rb antibody (Æ-pRb). As a control, proteins were immuno-
precipitated and immunoblotted with anti-pRb antibody. pRb depho-
sphorylation occurred in HBMEC in response to Acanthamoeba in a
time-dependent manner. (b) Genotype T4 Acanthamoeba isolate
induces pRB dephosphorylation in HCEC. Immortalized HCEC were
grown in 60 mm dishes and incubated with the T4 isolate as described
above. In the control, proteins were immunoprecipitated and immuno-
blotted with anti-pRb antibody. The Acanthamoeba T4 isolate induced
pRb dephosphorylation in HCEC similar to HBMEC, but over a longer
period of time.
Host cell-cycle arrest induced by Acanthamoeba
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issues. Overall, we observed that Acanthamoeba produced
pRb dephosphorylation and induced G1-to-S phase check-
point arrest.
It is important to emphasize that cell-cycle arrest is the
outcome of a complex signalling network that requires a fine
balance between growth-stimulating and growth-inhibition
pathways and is not as straightforward as discussed here. For
example, some genes such as MCM7 and CDC27 exhibited
gene expression in accordance with cell-cycle progression
rather than cell-cycle arrest. However, the majority of genes
analysed exhibited gene expression in compliance with cell-
cycle arrest, which contributes to the overwhelming signal-
ling pathways that result in the cellular decision to undergo
cell-cycle arrest.
In conclusion, we have shown for the first time that
Acanthamoeba induces differential expression of various
genes crucial for G1-to-S transition and G2-to-M transitions
with the collective response of host cell-cycle inhibition.
These results were confirmed at the protein level by showing
that Acanthamoeba abolished pRb phosphorylation in host
cells and induced G1-to-S phase checkpoint arrest. Further
understanding of the mechanisms associated with Acantha-
moeba–host cell interactions will undoubtedly help to
develop novel targets to treat Acanthamoeba infections.
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